Papillary thyroid cancer is a common endocrine cancer and commonly presents with lymph node metastases. It has been generally accepted that lymphatic drainage occurs from the thyroid primarily to the central lymphatic compartment and secondarily to the lateral compartment nodes. Recently, improvements in the resolution of imaging studies and the availability of highly sensitive thyroglobulin assays have highlighted the importance of identifying disease in the pre-operative assessment and dealing effectively with metastatic regional disease in order to prevent recurrence. However, there are limitations to diagnosing central lymph node metastases. With unreliable imaging modalities, prophylactic central lymph node dissection should be performed on all patients with papillary thyroid cancer. In comparison with the central compartment, prophylactic lateral node dissection has little or no effect on improving the prognosis of patients with papillary thyroid cancer. Therefore, lateral node dissection is recommended only as a part of the therapeutic procedure. The extension of lateral neck dissection is recommended a comprehensive selective neck dissection of levels IIa, III, IV, and Vb. The rich lymphatic supply of the thyroid gland coupled with the propensity for nodal metastases in papillary thyroid cancer require the modern thyroid surgeon to be familiar with the indications for and techniques of regional lymph node dissection.
Introduction
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, with an increasing incidence of, now, approximately 8.7 cases/100,000 per year. 1) Overall, the 10-year disease-specific survival rate for PTC is 90%.
2) Despite this excellent prognosis, cervical lymph node metastases are found in 40-90% of cases, andup to 20% of patients encounter recurrence of PTC after their primary operation. [3] [4] [5] Almost four-fifths of all PTC recurrences occur in the neck alone, and, of these, three-fourths are associated with lymph node metastases. 6, 7) Because of its high incidence, regional lymph node metastasis has long been a critical issue with PTC. However, the true impact of local lymph node metastasis on survival in PTC remains controversial.
Nonetheless, there are ample data in the literature associating lymph node metastasis with decreased disease-specific survival and increased risk of local recurrence. Outcome data from large institutional cohorts from the United States, Canada, and Germany have shown a significant and independent negative impact on survival with lymph node metastasis. [8] [9] [10] Analysis of large cancer registry databases from the United States and Sweden has similarly shown poorer outcomes and increased mortality rate inpatients with locoregional lymph node metastases. 11, 12) Additionally, recurrence. 13) Recently, improvements in the resolution of imaging studies and the availability of highly sensitive thyroglobulin assays have highlighted the importance of identifying disease in the pre-operative assessment and dealing effectively with metastatic regional disease in order to prevent recurrence. The aim of this review is to describe the contemporary approach to assessment and management of regional lymph node metastasis in PTC.
Lymphatic Drainage of the Thyroid
Accurate characterization and prediction of lymphatic drainage of the thyroid gland is technically challenging because it is extensive and flows in many directions. Some authors have reported that each lobe of the thyroid gland has its own internal lymphatic system, and there is no communication with contralateral regional lymph nodes 14, 15) (although PTC can spread to regional lymph nodes bilaterally [16] [17] [18] ) It has been generally accepted that lymphatic drainage occurs from the thyroid primarily to the central lymphatic compartment and secondarily to the lateral compartment nodes. 19, 20) As a result, locoregional spread of thyroid cancer predominantly involves the ipsilateral, and sometimes also the contralateral central and lateral neck nodes. [21] [22] [23] [24] Dralle and Machens 25) suggested that lymphatic tu- Recently several investigators have reported that preoperative US with CT had superior diagnostic performances to US alone, although the routine preoperative usage of CT is not recommended by the American Thyroid Association (ATA) guidelines under revision. 33, 35, 36) However, US and CT together were still not sufficiently sensitive to detect small lymph node metastases in the central neck.
Central Neck Dissection
Lymph nodes in the central compartment are from the thyroid notch to the innominate artery cephalocaudal, and from one carotid artery to the other.
Central neck dissection refers to the systematic excision of the prelaryngeal, pretracheal, and paratracheal lymph nodes that reside in the level VI compartment of the neck, and can be unilateral or bilateral. 37) In This inconsistency between published guidelines for prophylactic lymph node dissection could be attributable to the lack of unbiased information on the patterns of lymph node metastases.
Proponents of routine prophylactic central neck dissection argue that lymph node metastases occur in 21-82% of cases 43) and that removing involved nodes reduces disease persistence. An argument against routine prophylactic central neck dissection is the absence of evidence for improvement of long-term outcomes. Furthermore, clinically apparent metastatic lymphadenopathy (i.e., larger size, greater number, and extranodal extension) has a much worse prognosis than microscopic lymph node metastases, [44] [45] [46] thus the long-term benefit of resection of occult microscopic nodal metastases is unclear. Other important concerns include increased risks of temporary hypocalcaemia after central neck dissection (compared with no neck dissection). 47, 48) Some medical evidence suggests that prophylactic central neck dissection leads to decreased overall or disease-associated mortality in low-risk PTC. Two meta-analyses 48, 49) 
Lateral Neck Dissection
Metastatic PTC to the lateral compartment is clinically significant as it is thought to be a predisposing condition to distant metastasis. Due to the increasing incidence of thyroid cancer over the past four decades, there may also be a rise in the number of patients presenting with lateral neck disease and requiring neck dissection. 1, 56) Historically, the management of lateral lymph node metastasis varies from "berry-picking" to modified radical neck dissection, 57) and there is still no clear consensus regarding the appropriate neck level to which nodes must be removed. (Fig. 1) . 59) In the absence of significant lymphadenopathy at levels IIa, III, IV and Vb, disease above the spinal accessory nerve (IIb or Va) or in level I is uncommon.
Sparing these lymph node basins will minimize risk of injury to the marginal mandibular and accessory nerves, whilst also preserving the submandibular salivary gland. Therefore, the ATA recommended a comprehensive selective neck dissection of levels IIa, III, IV, and Vb. 59) In comparison with the central compartment, the lateral neck harbors lower rates (23%) 60) of occult metastasis and elective surgery results in higher postoperative complication rates. Despite this, some experts continue to advocate selective prophylactic lateral neck dissection.
Such groups report rates of occult disease greater than 20%, low rates of complication in their hands and more accurate staging of initial disease. 60) However, even expert groups report complication rates as high as 50%
following total thyroidectomy and lateral neck dissection, including hypocalcemia (30%), chronic neck pain (30%), chyle leak (3%) and recurrent laryngeal nerve palsy (10%). 61) There have been many studies suggesting that prophylactic lateral node dissection has little or no effect on improving the prognosis of patients with PTC.
A similarly good prognosis can be achieved by a salvage operation after lymph node recurrence in the lateral compartment, in comparison to prophylactic node dissection. Therefore, lateral node dissection is recommended only as a part of the therapeutic procedure.
Conclusion
The rich lymphatic supply of the thyroid gland cou- 
